This mechanism raises concerns about potential synergistic effects when co-administered with sedative-hypnotic medications, such as benzodiazepines or barbiturates, highlighting the need for caution
For example, when investigating the hypothesis that gap junctions transport toxic metabolites to neighboring cells and support their killing during APAP and thioacetamide hepatotoxicity, the fact that the new gap junction inhibitor 2-aminoethoxydipenyl-borate (2APB) protected against the injury appeared to support the hypothesis [154]
The trial design was published in Alzheimers Research & Therapy (2025)
Retatrutide may produce gastrointestinal symptoms similar to other GLP-1based therapies
Track results over multiple weeks, as sleep architecture changes often take time to manifest in subjective improvements
Vitamin D Sources, Metabolism, and Deficiency: Available Compounds and Guidelines for its Treatment